642 related articles for article (PubMed ID: 17192159)
1. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
[TBL] [Abstract][Full Text] [Related]
2. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448
[TBL] [Abstract][Full Text] [Related]
3. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
[TBL] [Abstract][Full Text] [Related]
4. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T
J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966
[TBL] [Abstract][Full Text] [Related]
5. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
6. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
7. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study.
Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP
Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471
[TBL] [Abstract][Full Text] [Related]
8. New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder.
Erickson SC; Le L; Zakharyan A; Stockl KM; Harada AS; Borson S; Ramsey SD; Curtis B
J Am Geriatr Soc; 2012 Mar; 60(3):474-9. PubMed ID: 22288652
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
Sankaranarayanan J; Puumala SE
Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
[TBL] [Abstract][Full Text] [Related]
10. The implications of weight changes with antipsychotic treatment.
Sussman N
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
[TBL] [Abstract][Full Text] [Related]
11. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
McIntyre RS; Jerrell JM
Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic-induced type 2 diabetes: evidence from a large health plan database.
Gianfrancesco F; White R; Wang RH; Nasrallah HA
J Clin Psychopharmacol; 2003 Aug; 23(4):328-35. PubMed ID: 12920407
[TBL] [Abstract][Full Text] [Related]
13. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
Ketter TA; Nasrallah HA; Fagiolini A
Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
[TBL] [Abstract][Full Text] [Related]
14. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
Ward A; Ishak K; Proskorovsky I; Caro J
Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
[TBL] [Abstract][Full Text] [Related]
15. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.
Morrato EH; Druss B; Hartung DM; Valuck RJ; Allen R; Campagna E; Newcomer JW
Arch Gen Psychiatry; 2010 Jan; 67(1):17-24. PubMed ID: 20048219
[TBL] [Abstract][Full Text] [Related]
16. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study.
Hippisley-Cox J; Vinogradova Y; Coupland C; Parker C
Arch Gen Psychiatry; 2007 Dec; 64(12):1368-76. PubMed ID: 18056544
[TBL] [Abstract][Full Text] [Related]
17. Hospitalisation risks in the treatment of schizophrenia in a Medicaid population: comparison of antipsychotic medications.
Gianfrancesco F; Wang RH; Pesa J; Rajagopalan K
Int J Clin Pract; 2006 Nov; 60(11):1419-24. PubMed ID: 17073838
[TBL] [Abstract][Full Text] [Related]
18. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
19. The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy.
Gianfrancesco F; Wang RH; Nasrallah HA
Ann Clin Psychiatry; 2006; 18(1):9-17. PubMed ID: 16517448
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic use and the risk of diabetes in nursing home residents with dementia.
Jalbert JJ; Daiello LA; Eaton CB; Miller SC; Lapane KL
Am J Geriatr Pharmacother; 2011 Jun; 9(3):153-63. PubMed ID: 21596626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
